Hamilton Medical AG
Hamilton Medical AG, headquartered in Switzerland (CH), is a leading innovator in the medical technology industry, specialising in advanced ventilation solutions. Founded in 1983, the company has established a strong presence in Europe, North America, and Asia, focusing on critical care and anaesthesia. Hamilton Medical is renowned for its cutting-edge ventilators and intelligent ventilation software, which enhance patient outcomes through precision and adaptability. Their flagship products, such as the HAMILTON-G5 and HAMILTON-C6, are distinguished by their unique features, including adaptive support modes and user-friendly interfaces. With a commitment to research and development, Hamilton Medical AG has achieved significant milestones, positioning itself as a trusted partner in hospitals worldwide. The company’s dedication to innovation and quality has earned it a prominent market position, making it a preferred choice among healthcare professionals in critical care settings.
DitchCarbon Score
How does Hamilton Medical AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hamilton Medical AG's score of 34 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hamilton Medical AG's reported carbon emissions
In 2024, Hamilton Medical AG reported total carbon emissions of approximately 151,254,000 kg CO2e. For the previous year, 2023, the company disclosed emissions across all three scopes: Scope 1 emissions were about 500,000 kg CO2e, Scope 2 emissions totalled approximately 1,500,000 kg CO2e, and Scope 3 emissions reached about 273,928,000 kg CO2e. Notably, the Scope 3 emissions figure remained consistent with that reported in 2020. Hamilton Medical AG has set ambitious climate commitments aligned with the Science Based Targets initiative (SBTi). The company aims to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2020 as the base year. Additionally, it targets a 52% reduction in Scope 3 emissions per CHF value added within the same timeframe. These targets reflect a commitment to significant emissions reductions, consistent with the global goal of limiting temperature rise to 1.5°C. The emissions data and reduction targets are cascaded from Hamilton Medical AG's corporate family structure, with the SBTi targets originating from the company itself. The commitment to these targets underscores Hamilton Medical AG's proactive approach to addressing climate change and enhancing sustainability within the healthcare equipment sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2023 | |
|---|---|---|
| Scope 1 | 750,000 | 000,000 |
| Scope 2 | 1,750,000 | 0,000,000 |
| Scope 3 | 273,928,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hamilton Medical AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
